Gara Jalqabaatti › Luukemiya Mayiloodii Faasii Keessummaa › Alabama › Birmingham
Qorannoo klinikaalii Luukemiya Mayiloodii Faasii Keessummaa Birmingham, AL keessatti
Qorannoo 3 Luukemiya Mayiloodii Faasii Keessummaa f Birmingham fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Study of Olverembatinib (HQP1351) in Patients With CML-CP
Namoota walitti qabaa jiraSadarkaa 3
- Ascentage Investigative Site #1044, Birmingham
A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
Namoota walitti qabaa jiraQorannoo ilaalaa
- University of Alabama at Birmingham, Birmingham
A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Alabama Medicine (UAB Medicine), Birmingham
Qorannoo Luukemiya Mayiloodii Faasii Keessummaa magaalota biroo keessatti
Qorannoo biroo Birmingham keessatti
- Saree (Gosoota Hunda)Qorannoo 30
- Saree OljooQorannoo 24
- ObesityQorannoo 23
- Kansarii OvariiQorannoo 23
- Kansara Qara'a Non-Small CellQorannoo 22
- Leukemia Myeloidii HamaaQorannoo 21
- Myeloma Baay’eeQorannoo 18
- COPDQorannoo 17
- Dhibee Onneessaa fi DhiigaQorannoo 17
- Baayyee UlfaataaQorannoo 16
- Kansa EndometiriyaaliiQorannoo 16
- Sukkaraa Gosa 2Qorannoo 16
Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.